The estimated Net Worth of Douglas Beck is at least 413 千$ dollars as of 16 June 2021. Mr. Beck owns over 1,000 units of Beyond Air stock worth over 8,690$ and over the last 6 years he sold XAIR stock worth over 0$. In addition, he makes 404,179$ as Chief Financial Officer at Beyond Air.
Douglas has made over 6 trades of the Beyond Air stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of XAIR stock worth 5,380$ on 16 June 2021.
The largest trade he's ever made was buying 9,710 units of Beyond Air stock on 3 June 2019 worth over 50,007$. On average, Douglas trades about 2,808 units every 93 days since 2018. As of 16 June 2021 he still owns at least 22,460 units of Beyond Air stock.
You can see the complete history of Mr. Beck stock trades at the bottom of the page.
Douglas J. Beck CPA serves as Chief Financial Officer of the Company. He was the Chief Financial officer of JLM Couture Inc, from February 16 until October 31, 2018, the Chief Financial Officer of Relmada Therapeutics, Inc. from December 2013 and was the Chief Financial Officer for iBio, Inc. from January 2011 to March 2013. In addition, Mr. Beck serves on the New York State Society of CPAs Chief Financial Officer and SEC committee. Mr. Beck is a graduate of Fairleigh Dickinson University and is a licensed certified public accountant in New York.
As the Chief Financial Officer of Beyond Air, the total compensation of Douglas Beck at Beyond Air is 404,179$. There are 5 executives at Beyond Air getting paid more, with Steven Lisi having the highest compensation of 2,969,660$.
Douglas Beck is 58, he's been the Chief Financial Officer of Beyond Air since 2018. There are 3 older and 9 younger executives at Beyond Air. The oldest executive at Beyond Air, Inc. is Michael A. Gaul, 65, who is the Sr. VP of Operations.
Douglas's mailing address filed with the SEC is C/O BEYOND AIR, INC., 825 EAST GATE BOULEVARD, SUITE 320, GARDEN CITY, NY, 11530.
Over the last 5 years, insiders at Beyond Air have traded over 4,582,444$ worth of Beyond Air stock and bought 3,519,117 units worth 12,396,434$ . The most active insiders traders include Robert Carey、Steven A. Lisi、Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of 15,492$. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth 18,500$.
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Beyond Air executives and other stock owners filed with the SEC include: